Navigation Links
Cord Blood America: Court Grants Motion to Dismiss at Lawsuit Aimed at Blocking Acquisition
Date:4/5/2011

LAS VEGAS, April 5, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that the Pinellas County Circuit Court granted a motion to dismiss the lawsuit filed by Cryo-Cell International against Cord Blood America, which CBAI management believed was an attempt to inhibit the pending deal between Cryo-Cell Mexico and CBAI.

"We're delighted. When I first addressed this issue publicly on Dec 17th, I stated that this was a suit without merit, and we knew we needed to defend ourselves; even at great time and cost to the company.  The lawsuit was a menace and we are pleased with the outcome.  Hats off to our counsel for a job well done and to the judicial system for seeing this through to a motion to dismiss," said Matthew Schissler, Cord Blood America's Chairman, CEO and co-founder.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring
2. New England Cord Blood Bank: Umbilical Cord Tissue Banking
3. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
4. Cord Blood America Announces Affiliate Program to Educate on Value of Umbilical Cord Blood Stem Cell Storage
5. New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
6. Global Growth Factors ( Blood And Tissue ) Industry
7. Cellectis and the Etablissement Francais du Sang Launch StemRed, a Program to Produce Red Blood Cells From Stem Cells
8. Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
9. China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results
10. China Cord Blood Corporation Forms Zhejiang Subsidiary
11. China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Jordan, Utah (PRWEB) , ... January 23, 2017 , ... ... has been named an INTERNET TELEPHONY Product of the Year Award winner for 2017. ... an industry leader in unified communications solutions. In 2016, CallTower was awarded with the ...
(Date:1/21/2017)... ... January 21, 2017 , ... Nova Oculus Partners has forged ... medical device for the treatment of Age-Related Macular Degeneration. , The company’s chief ... regulatory consultancy that helps companies like ours secure government approvals for their medical ...
(Date:1/21/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... and commercialization of innovative biopharmaceutical products for companion animals, ... North America 2016. ... the FDA approval of three innovative therapeutics in 2016, ... oral solution) and NOCITA ® (bupivacaine liposome injectable ...
(Date:1/20/2017)... 2017 Stock-Callers.com explores the Biotech ... the most recent performances of select equities. In this ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ABEO ... and Sage Therapeutics Inc. (NASDAQ: SAGE ). ... Research, global Biotech market size is expected to reach $604.40 billion by 2020 ...
Breaking Biology Technology:
(Date:12/15/2016)... Mich. , Dec. 15, 2016  There is ... car doors or starting the engine. Continental will demonstrate ... Las Vegas . Through the combination ... Start and Entry) and biometric elements, the international technology ... of vehicle personalization and authentication. "The integration ...
(Date:12/8/2016)... -- Market Research Future published a half cooked research report on ... and Service Market is expected to grow over the CAGR of ... ... Mobile Biometric Security and Service Market is increasing ... authentication and security from unwanted cyber threats. The increasing use of ...
(Date:12/7/2016)... TEL AVIV, Israel , December 7, 2016 ... year with the expansion of its patent portfolio, which grew to over ... , , ... led by its recently filed patent entitled " System, Device, ... which covers technology that enables device makers to forego costly hardware components ...
Breaking Biology News(10 mins):